540 related articles for article (PubMed ID: 15833846)
21. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.
Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T
Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811
[TBL] [Abstract][Full Text] [Related]
22. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells.
Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Iwashita K; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S
Cancer Lett; 2008 Oct; 270(1):156-63. PubMed ID: 18583030
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells.
Wang W; Cassidy J; O'Brien V; Ryan KM; Collie-Duguid E
Cancer Res; 2004 Nov; 64(22):8167-76. PubMed ID: 15548681
[TBL] [Abstract][Full Text] [Related]
24. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
Yoo BC; Jeon E; Hong SH; Shin YK; Chang HJ; Park JG
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4176-84. PubMed ID: 15217955
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
[TBL] [Abstract][Full Text] [Related]
26. Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase.
Santamaría G; Martínez-Diez M; Fabregat I; Cuezva JM
Carcinogenesis; 2006 May; 27(5):925-35. PubMed ID: 16361271
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia.
Grover GJ; Malm J
Cardiovasc Ther; 2008; 26(4):287-96. PubMed ID: 19035880
[TBL] [Abstract][Full Text] [Related]
29. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells.
Wu X; Deng Y; Wang G; Tao K
J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374
[TBL] [Abstract][Full Text] [Related]
30. Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease.
Grover GJ; Marone PA; Koetzner L; Seto-Young D
Int J Biochem Cell Biol; 2008; 40(12):2698-701. PubMed ID: 18707016
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells.
Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H
Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755
[TBL] [Abstract][Full Text] [Related]
32. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
[TBL] [Abstract][Full Text] [Related]
33. Silencing hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.
Peng Q; Zhou J; Zhou Q; Pan F; Zhong D; Liang H
Hepatogastroenterology; 2009; 56(90):355-60. PubMed ID: 19579598
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
[TBL] [Abstract][Full Text] [Related]
35. Atypical subunit composition of the chlorophycean mitochondrial F1FO-ATP synthase and role of Asa7 protein in stability and oligomycin resistance of the enzyme.
Lapaille M; Escobar-Ramírez A; Degand H; Baurain D; Rodríguez-Salinas E; Coosemans N; Boutry M; Gonzalez-Halphen D; Remacle C; Cardol P
Mol Biol Evol; 2010 Jul; 27(7):1630-44. PubMed ID: 20156838
[TBL] [Abstract][Full Text] [Related]
36. Nifedipine synergizes with calcium in activating the calcium sensing receptor, suppressing the expression of thymidylate synthase and survivin and promoting sensitivity to fluorouracil in human colon carcinoma cells.
Liu G; Hu X; Premkumar L; Chakrabarty S
Mol Carcinog; 2011 Dec; 50(12):922-30. PubMed ID: 21374737
[TBL] [Abstract][Full Text] [Related]
37. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
[TBL] [Abstract][Full Text] [Related]
38. CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells.
Takagi K; Sowa Y; Cevik OM; Nakanishi R; Sakai T
Int J Oncol; 2008 May; 32(5):1105-10. PubMed ID: 18425338
[TBL] [Abstract][Full Text] [Related]
39. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
40. Synergism between a siRNA targeted to survivin and 5-FU in inhibiting MCF-7 cell proliferation in vitro.
Zhang SQ; Zhang SH; Xue XH; Wang XJ; Jiang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):251-4. PubMed ID: 16546719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
